More than 5 million more Americans file for unemployment as the monthly total surpasses 22 million. Abbott Labs gets a boost on optimism over its coronavirus testing. Gilead Sciences gets a boost on optimism over its coronavirus treatment. Procter & Gamble reports its biggest U.S. sales gain in decades. Amazon hits an all-time high. Comcast launches a previe ... Show More
Yesterday
When Leverage Goes Wrong on Wall Street
The week was dominated by hedge fund Situational Awareness being forced to sell its equity holdings, leading to both a drop and a pop in AI-related stocks. What went wrong and what can we learn? Plus, we discuss why hyperscalers are moving in opposite directions, why Tesla may le ... Show More
40m 43s
Jul 30
Microsoft Shows the Mag7 What AI Investment Looks Like
Investors are taking a more scrutinous approach to all of the capital spending the Mag7 stocks are throwing at AI data centers. The one standout this quarter (so far) is Microsoft. Matt, Lou, and Tyler break down why investors loved Microsoft’s earnings while hating Meta’s, and w ... Show More
21m 38s
Jul 29
The Consumer Is All Right!
Earnings season has shown us that consumers are still spending and paying their bills, as indicated by SoFi and Visa’s results. That should give investors some confidence as more companies report. Where there are more questions is in the AI trade, which continues to falter, despi ... Show More
20m 27s
Nov 2021
Job Creation Roars Back, Labor Secretary Marty Walsh, Pfizer’s Covid-19 Pill, Peloton Gets Smacked
Carl Quintanilla and Jim Cramer begin the morning discussing Pfizer’s announcement that its experimental COVID-19 pill reduces the risk of death and hospitalization by 89%. Shares of Pfizer surging on the news. Plus, job creation roaring back in October as payrolls rose by 531,0 ... Show More
42m 52s
Dec 2021
Pfizer & BioNTech Share Results on Boosters as Job Openings Near All-Time High
DB-Dec08,2021:With markets easing on Omicron fears this week and assets across the board beginning to recover from last week’s drawdowns, Pfizer and BioNTech both announced today the initial findings of the effectiveness of their boosters against the Omicron variant, demonstratin ... Show More
38m 7s
May 2021
Pfizer’s Results, What’s Next for Retail & Restaurants, The High Bar for CRISPR & More
<p>It has been a busy few days for the United States as the pandemic-related news has been fast and furious. Pfizer reported better-than-expected profits and a lot of its revenue has come from the COVID-19 vaccine. Maxx Chatsko joins Dan Kline to talk about that, President Joe Bi ... Show More
58m 18s